UniFAHS is a pioneering biotechnology company founded in 2020 and based in Southeast Asia. The company's slogan "Unique Phage-based Solution for Food, Animal, Human Safety, and Sustainability" encapsulates its mission of providing sustainable alternatives to antibiotics and chemicals. UniFAHS leverages phage biotechnology to ensure the safety and sustainability of the food supply chain, offering solutions that are beneficial for animals, people, and the planet. In its latest funding round on 04 January 2024, UniFAHS secured a significant investment of $1.40M from prominent venture capital firms, including ADB Ventures, A2D Ventures, and InnoSpace Thailand. This investment underscores the growing recognition of UniFAHS's innovative technologies and its potential to make a meaningful impact in the biotechnology industry. As the company continues to expand its reach and influence in Southeast Asia and beyond, its commitment to sustainability and safety positions it as an attractive prospect for investors seeking to support impactful and forward-thinking ventures in the biotechnology sector. UniFAHS's focus on addressing critical challenges in food, animal, and human safety aligns with current trends and demands for sustainable and ethical solutions, further solidifying its potential for long-term success and positive environmental and societal impact.
No recent news or press coverage available for UniFAHS.